Tue, Jul 22, 2014, 5:10 AM EDT - U.S. Markets open in 4 hrs 20 mins

Recent

% | $
Click the to save as a favorite.

Astex Pharmaceuticals, Inc. Message Board

  • mcj96 mcj96 Sep 5, 2013 9:26 AM Flag

    S V N T....is next......The last co Dr Meeker was on the bd of was Penwest Pharma which was acquired for $5/sh

    That's about the price SVNT will fetch in a YE sale........SVNT currently sells for LESS....than 1x 2014 rev estimates.......Does ASTX sell for less than 1x sales ?......My humble recommendation: Use some of your profits to buy SVNT at less than 1x sales.........SVNT's orphan drug Krystexxa is a rare disease therapy that currently sells for only $5,390/dose........Once Krystexxa is priced like peer group rare disease therapies like Acthar, which sells for over $34,000/dose, SVNT's US revs alone will hit about $350 mil......SVNT's breakeven is about $95-$100 mil and SVNT's margins are currently around 80%. Even after giving Duke 8-12% royalties SVNT will still have huge earnings power going forward. Krystexxa 's patent also runs till 2026. Good luck to all.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ASTX
8.4950.000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.